AP
PARN

Atwood & Palmer’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History

Atwood & Palmer’s Portfolio PARN Stock Details PARN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-16,900
Closed -$12K – 359
2016
Q4 		$12K Hold
16,900
– – ﹤0.01% 259
2016
Q3 		$24K Hold
16,900
– – ﹤0.01% 218
2016
Q2 		$28K Buy
16,900
+10,000
+145% +$18.4K 0.01% 204
2016
Q1 		$15K Buy
+6,900
New +$19K ﹤0.01% 246

Other funds holding PARN

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Atwood & Palmer's PARN Position: Q1 2017 in Review

Atwood & Palmer sold out of Parnell Pharmaceuticals Holdings Ltd (PARN) in Q1 2017, closing a stake of 16,900 shares — an estimated $12K sold.

Atwood & Palmer first reported a position in PARN in Q1 2016 and held it in 4 quarters. The position peaked at $28K in Q2 2016. 2 funds tracked by Wall St. Rank hold PARN as of Q1 2017.

  • Atwood & Palmer reported no remaining Parnell Pharmaceuticals Holdings Ltd position as of Q1 2017 after selling out during the quarter.
  • Atwood & Palmer sold 16,900 Parnell Pharmaceuticals Holdings Ltd shares in Q1 2017, an estimated $12K.
  • Atwood & Palmer first reported a position in Parnell Pharmaceuticals Holdings Ltd in Q1 2016 and held it in 4 quarters.
  • Atwood & Palmer's Parnell Pharmaceuticals Holdings Ltd position peaked at $28K in Q2 2016.
  • 2 funds tracked by Wall St. Rank held Parnell Pharmaceuticals Holdings Ltd as of Q1 2017.

Based on Atwood & Palmer's 13F filing for Q1 2017, filed 28 Apr 2017.